LXRX — Lexicon Pharmaceuticals, Inc. stock price, charts and financials

QT64Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
2.49
+0.16+6.87%
OverviewShort InterestFilings
LXRXQT64Lexicon Pharmaceuticals, Inc.·NASDAQ
2.49+6.87%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
May 08, 20264Statement of changes in beneficial ownership
May 08, 2026SC 13D/ABeneficial ownership statement (active, amended)
May 07, 20268-KCurrent report
May 07, 202610-QQuarterly report
May 06, 20268-KCurrent report
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
Apr 30, 20268-KCurrent report
Mar 16, 2026ARSAnnual report to shareholders
Mar 16, 2026DEF 14ADefinitive proxy statement
Mar 16, 2026DEFA14AAdditional proxy soliciting materials
Mar 05, 20268-KCurrent report
Mar 05, 202610-KAnnual report
#1 / 25 of 353
Page
▼
/ 15